13th International Symposium on Minimal Residual Cancer

Dear Colleagues and Friends, 

We would like to warmly welcome you to the 13th International Symposium on Minimal Residual Cancer (ISMRC) in Hamburg, Germany. The ISMRC meetings were initiated in 1996 and have established themselves as premier events focusing on biology, technologies and in particular clinical applications of “Liquid Biopsy” in cancer patients.

Following a COVID-19 induced break, the symposium will return to its origin, Germany and take place as an in-person event from May 2 - 4 , 2023. This international meeting is a great opportunity to gather for three days and share information on the most recent developments with leading researchers in the oncology, immunology and liquid biopsy fields. The congress programme will include presentations on circulating nucleic acids (DNA, miRNA), Circulating Tumor Cells (CTCs), and exosomes and other liquid biopsy analytes, with emphasis on clinical and translational studies and a strong focus on immunotherapy.

The 2023 meeting in Hamburg is supported by the European Liquid Biopsy Society (ELBS), a large consortium of institutions from academia and industry with the vision of bringing liquid biopsy assays into clinical practice.

Plenary talks will be given by leading international experts in the fields of liquid biopsy, cancer immunology, metastasis research and immunotherapy, including the Nobel Prize laureate Tasuko Honjo from Kyoto, Japan. Besides these plenary talks, the ISMRC supports young investigators through selected oral communications as part of the plenary sessions and poster presentations. Outstanding presentations will be awarded with our “Young investigator awards”! 

Please submit your abstract for consideration by our Advisory Committee until February 21, 2023.